Case report: A mesenchymal chondrosarcoma with alternative

Satsuki Kishikawa, Akihide Kondo, Takashi Yao, Tsuyoshi Saito

Abstract readCase Reports

In one paragraph

Article in Pathology oncology research : POR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Mesenchymal Chondrosarcoma of the Mandible, a Big Dilemma: Report of a Rare Case in Mesenchymal Chondrosarcoma of the Mandible-Report of a Case With Discussion of Diagnostic and Therapeutic Dilemmas.Case reports in dentistry · 2024
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Satsuki KishikawaDepartment of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Akihide KondoDepartment of Neurosurgery, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Takashi YaoDepartment of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Tsuyoshi SaitoDepartment of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS) is one of the most common origins of extraosseous MCS. However, alternative Case report: We report a case of intracranial MCS with Discussion: Cartilaginous components were often not apparent during the recurrences. In addition to the non-typical pathological finding, the correct diagnosis was hampered by the poor RNA quality of the surgical specimens and non-specific STAT6 nuclear staining. Conclusion: This is the first reported case of intracranial MCS with an alternative

Indexed as

Basic Helix-Loop-Helix ProteinsCell Cycle ProteinsChondrosarcoma, MesenchymalNuclear Receptor Coactivator 2Sella TurcicaFemaleHumansMiddle AgedBasic Helix-Loop-Helix ProteinsCell Cycle ProteinsHEY1 protein, humanNCOA2 protein, humanNuclear Receptor Coactivator 2CNS sarcomaHEY1::NCOA2intracranial mesenchymal chondrosarcomamesenchymal chondrosarcomasella turcica

Identifiers

PMID39165647

DOI10.3389/pore.2024.1611730

PMCPMC11333213

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.